US equities |
TSLA $394.37 ▲+5.95% MU $907.12 ▲+3.37% SPCX $149.19 ▲+1.15% NVDA $215.50 ▲+2.15% META $641.36 ▼-0.20% SNDK $1,263.03 ▲+2.02% AAPL $344.88 ▼-0.82% INTC $90.68 ▲+4.28%
FinancialContent

Definium Therapeutics, Inc. - Common Shares (NQ:DFTX)

36.23 +0.56 (+1.57%)
Delayed Quote Updated: 12:04 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Definium Therapeutics, Inc. - Common Shares

< Previous 1 2 3 Next >
News headline image
Definium Therapeutics to Participate at Upcoming Investor Conferences
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Announces New Employee Inducement Grants
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Appoints Roger Adsett to Board of Directors
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Announces New Employee Inducement Grants
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
2026 Asset Growth: Why Federal Compliance Is the New Metric
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. 
From Equity Insider
Via GlobeNewswire
< Previous 1 2 3 Next >